We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,253 hedge funds and large institutions have $38.2B invested in Edwards Lifesciences in 2025 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 444 increasing their positions, 443 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more first-time investments, than exits

New positions opened: 113 | Existing positions closed: 106

0% more repeat investments, than reductions

Existing positions increased: 444 | Existing positions reduced: 443

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

0% less funds holding

Funds holding: 1,259 → 1,253 (-6)

3% less capital invested

Capital invested by funds: $39.4B → $38.2B (-$1.2B)

1.96% less ownership

Funds ownership: 85.71% → 83.75% (-2%)

13% less call options, than puts

Call options by funds: $295M | Put options by funds: $337M

Holders
1,253
Holders Change
-6
Holders Change %
-0.48%
% of All Funds
16.44%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
113
Increased
444
Reduced
443
Closed
106
Calls
$295M
Puts
$337M
Net Calls
-$42.4M
Net Calls Change
-$147M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$942M
2
UBS AM
UBS AM
Illinois
+$321M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$240M
4
Jennison Associates
Jennison Associates
New York
+$179M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$111M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$664M
2
Millennium Management
Millennium Management
New York
-$383M
3
Marshall Wace
Marshall Wace
United Kingdom
-$260M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$180M
5
JP Morgan Chase
JP Morgan Chase
New York
-$134M
Name Holding Trade Value Shares
Change 		Change in
Stake
GA
1176
Guerra Advisors
Florida
$5.05K +$5.08K +65 New
CCM
1177
Cloud Capital Management
Washington
$5K +$5.16K +66 New
PWMG
1178
Private Wealth Management Group
New Jersey
$4.98K – – –
HFM
1179
Hartford Financial Management
Connecticut
$4.9K +$2.58K +33 +110%
FP
1180
Financial Perspectives
Minnesota
$4.82K – – –
CWP
1181
Clark Wealth Partners
Illinois
$4.69K – – –
NEWAS
1182
N.E.W. Advisory Services
Wisconsin
$4.59K – – –
HHGA
1183
Halbert Hargrove Global Advisors
California
$4.28K +$2.66K +34 +162%
LAM
1184
Lummis Asset Management
Texas
$4.12K – – –
BFS
1185
Bare Financial Services
Pennsylvania
$4.12K +$469 +6 +13%
DWM
1186
Dogwood Wealth Management
Kansas
$4.04K +$2.27K +29 +126%
HNW
1187
High Note Wealth
Minnesota
$3.97K -$3.91K -50 -50%
ADL
1188
Asset Dedication LLC
California
$3.81K – – –
AA
1189
Ancora Advisors
Ohio
$3.73K – – –
MSWM
1190
Mowery & Schoenfeld Wealth Management
Illinois
$3.58K – – –
FMP
1191
Financial Management Professionals
Texas
$3.58K -$1.09K -14 -23%
CTB
1192
Country Trust Bank
Illinois
$3.5K -$1.41K -18 -29%
DPW
1193
DiNuzzo Private Wealth
Pennsylvania
$3.42K +$156 +2 +5%
ACM
1194
Accent Capital Management
Ohio
$3.27K – – –
BLC
1195
Brown, Lisle/Cummings
Rhode Island
$3.27K – – –
DWM
1196
Darwin Wealth Management
Florida
$3.27K – – –
WA
1197
WPG Advisers
Maryland
$3.19K – – –
SC
1198
Swan Capital
Florida
$3.05K – – –
EWP
1199
Elevation Wealth Partners
California
$3.03K +$3.05K +39 New
PCM
1200
Penserra Capital Management
California
$3K -$234 -3 -6%
46 47
48
49 50

EW Hedge Fund Activity: Q3 2025 in Review

1,253 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q3 2025, worth a combined $38.2B — down 3% from $39.4B a quarter earlier.

Buyers outnumbered sellers: 113 funds opened new EW positions and 106 closed out — a net gain of 7 holders — while 444 added to existing stakes and 443 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $942M. The largest seller was Citadel Advisors, cutting an estimated $664M.

  • 1,253 institutional investors held Edwards Lifesciences (EW) as of Q3 2025, down from 1,259 in Q2 2025.
  • Funds reported $38.2B of Edwards Lifesciences stock for Q3 2025, down 3% quarter-over-quarter.
  • 113 funds opened new Edwards Lifesciences positions in Q3 2025 and 106 closed out, a net change of +7 holders.
  • The largest Edwards Lifesciences buyer in Q3 2025 was Fidelity Investments, an estimated $942M added.
  • The largest Edwards Lifesciences seller in Q3 2025 was Citadel Advisors, an estimated $664M sold.

Based on aggregated 13F filings for Q3 2025.